News & Trends - Pharmaceuticals
Sun Pharma’s novel ophthalmic treatment now TGA approved
Sun Pharma gains TGA approval of novel aqueous, nanomicellar ophthalmic ciclosporin solution, for treatment of moderate-to-severe keratoconjunctivitis sicca (dry eye), where prior use of artificial tears has not been sufficient.
CEQUA’s (ciclosporin 900 microgram/mL) novel delivery system, utilising nanomicellar technology, improves the formulation’s bioavailability and allows for a more than 10-fold increase in the aqueous solubility of ciclosporin.
According to leading Ophthalmologist from Vision Eye Institute, Associate Professor Colin Chan, Sydney, the TGA approval of an additional treatment option for dry eye disease will be welcomed by clinicians and patients alike, given the prevalence of the disease.
“Dry eye affects more than seven (7.4) per cent of the Australian population. The disease represents one of the most common reasons for seeking medical eye care, with a quarter of patients who visit ophthalmic clinics reporting symptoms of dry eye.
“Furthermore, one in five patients with dry eye are dissatisfied with their overall treatment due to lack of symptom relief, the time taken to relieve symptoms, and treatment side-effects,” said A/Prof Chan.
Ciclosporin is the first agent used in the treatment of dry eye to address the pathogenesis of the disease.
“The TGA’s approval of this novel treatment with improved solubility and tissue bioavailability, helps to fulfil a clinically unmet need for dry eye therapies especially for patients who don’t respond to previous therapies,” said A/Prof Chan.
CEQUA is a S4 product and requires a prescription. Sun Pharma is seeking PBS reimbursement for this product.
News & Trends - MedTech & Diagnostics
Stryker partners with local researchers to advance shoulder joint surgery
MedTech & Diagnostics News: Joint replacement is a commonly performed major surgical procedure that has considerable success in alleviating pain […]
MoreNews & Trends - Pharmaceuticals
Over two-thirds of Aussies missing healthcare appointments
Pharma News: Over 70% of Australians have postponed or cancelled healthcare appointments in the last 12 months. The primary reason […]
MoreNews & Trends - Pharmaceuticals
Opposition decries incremental change as New Zealand government defends Pharmac budget
Pharma News: New Zealand’s Associate Health Minister has made headlines by unveiling Pharmac’s largest ever budget of $6.294 billion over […]
MoreMedical
Telehealth’s 10-year leap in 10 days: Reshaping hospital EDs
Medical: As overcrowding and ramping continue to challenge emergency departments across Australia, the concept of virtual emergency departments (EDs) emerges […]
More